August 23, 2017The Journal of Clinical Pharmacology

Potential Drug–Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center

View Full Paper

Ask AI

Bookmark

Population

123 critically ill pediatric patients admitted to the pediatric intensive care unit of an academic pulmonary…

Design

Cohort

Follow-up

6 months

Authors

MHMaryam HassanzadMasih Daneshvari Hospital SASara Arenas-LópezGuy's and St Thomas' NHS Foundation Trust SBShadi BaniasadiMasih Daneshvari Hospital

Discussion

Member takes

Implication

Highlights a high prevalence of potentially dangerous polypharmacy in the pediatric intensive care.

Structured PICO

Population

123 critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) of an academic pulmonary hospital, primarily with respiratory system diseases (56.1%).

Outcome

Rate, pattern, risk factors, and management of potential drug-drug interactions (pDDIs)safety

Critically ill pediatric patients in the PICU are at high risk for major drug-drug interactions, highlighting the need for close cooperation between clinicians and clinical pharmacologists.

Cite This Study

Hassanzad et al. (2017) studied this question.

synapsesocial.com/papers/6a88f3cf161628139175faaa https://doi.org/10.1002/jcph.996

View Full Paper

Ask AI

Bookmark

Potential Drug–Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Potential Drug–Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider